Fungus-derived drug holds promise for various cancers

06/29/2008 | Reuters

U.S. scientists were able to target tumor cells and inhibit melanoma and lung cancer in mice without causing side effects after orally administering lodamin, a drug derived from the Aspergillus fumigatus fresenius -- a fungus accidentally discovered while cultivating endothelial cells. The drug -- an angiogenesis inhibitor developed through nanotechnology -- may prove useful in treating other cancers and conditions characterized by irregular blood vessel growth, the researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC